Experimental Lung Research · 2010 · 66 citations · 28 references
MedicineImmunologyPharmacologyImmunopathologyInflammationInnate ImmunityFibrosisInflammatory PathologyInterstitial Lung DiseaseMacrophage BiologyPulmonary InflammationPulmonary PathologyBleomycin InjectionFibrotic ChangeInnate Immunity PathwaysLung FibrosisLung Function DeclineLung Function TestingPulmonary Fibrosis ProgressionPulmonary Immunopathology
Idiopathic pulmonary fibrosis (IPF) is a devastating disease without proper treatment. Despite intensive research, the exact underlying pathogenesis remains elusive. It is regarded as a continuous injury, resulting in inflammation, infiltration, and proliferation of fibroblasts and extracellular matrix deposition, leading to an irreversible restrictive lung function deterioration and death. In this study the effect of azithromycin, a macrolide antibiotic on bleomycin-induced pulmonary fibrosis was investigated. C57BL/6 mice were intratracheally instilled with bleomycin (0.5 mg/kg) or saline. In the bleomycin group, half of the animals received azithromycin every other day from day 1 on. Bronchoalveolar lavage and histology were performed at days 7 and 35, and pulmonary function tests on day 35. At day 35, fibrotic lesions (spindle cell proliferation/collagen I deposition) were paralleled by a restrictive lung function pattern. Alterations were found in neutrophils and macrophages (innate immunity) and in T(H)2, T(H)17, and Treg cytokines (adaptive immunity). Azithromycin significantly reduced both fibrosis and the restrictive lung function pattern. This study demonstrated a beneficial effect of azithromycin on bleomycin-induced pulmonary fibrosis. A possible mechanism could be a modulation of both innate immunity and adaptive immunity. These findings might suggest a potential role for azithromycin in the treatment of IPF.
28
The IL-23/IL-17 axis in inflammation
Yoichiro Iwakura · Journal of Clinical Investigation · 2006 · 1.1K citations · Full text
Life Sciences, Immunology, Pathology +17
High-Dose Acetylcysteine in Idiopathic Pulmonary Fibrosis
Maurits Demedts, Roland Buhl, Ulrich Costabel et al. · New England Journal of Medicine · 2005 · 981 citations · Full text
Jeroen Vanoirbeek, Manuela Rinaldi, Vanessa De Vooght et al. · American Journal of Respiratory Cell and Molecular Biology · 2009 · 327 citations
Health Professions, Physiology, Pulmonary Function Testing +16
Baseline BAL Neutrophilia Predicts Early Mortality in Idiopathic Pulmonary Fibrosis
Brent W. Kinder, Kevin K. Brown, Marvin I. Schwarz et al. · CHEST Journal · 2007 · 303 citations
Medicine, Immunology, Pathology +16